This company has been acquired
Resumen de acción CNVY
Convey Health Solutions Holdings, Inc. provides technology enabled solutions and advisory services to assist its clients with workflows across product developments, sales, member experience, clinical management, core operations, and business intelligence and analytics.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en CNVY a partir de nuestros controles de riesgos.
Competidores de Convey Health Solutions Holdings, Inc.
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | US$10.51 |
52 Week High | US$10.73 |
52 Week Low | US$3.75 |
Beta | 0 |
1 Month Change | -0.095% |
3 Month Change | 0.48% |
1 Year Change | 29.91% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -19.15% |
Noticias y actualizaciones recientes
Rentabilidad de los accionistas
CNVY | US Healthcare Services | Mercado US | |
---|---|---|---|
7D | 0% | 1.0% | 1.6% |
1Y | 29.9% | -5.9% | 25.1% |
Rentabilidad vs. Industria: CNVY exceeded the US Healthcare Services industry which returned -52.5% over the past year.
Rentabilidad vs. Mercado: CNVY exceeded the US Market which returned -20.4% over the past year.
Volatilidad de los precios
CNVY volatility | |
---|---|
CNVY Average Weekly Movement | 0.5% |
Healthcare Services Industry Average Movement | 9.8% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CNVY has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: CNVY's weekly volatility has decreased from 21% to 1% over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
2001 | 3,105 | Steve Farrell | www.conveyhealthsolutions.com |
Resumen de fundamentos de Convey Health Solutions Holdings, Inc.
Estadísticas fundamentales de CNVY | |
---|---|
Capitalización bursátil | US$769.56m |
Beneficios(TTM) | -US$6.94m |
Ingresos (TTM) | US$366.21m |
2.1x
Ratio precio-ventas (PS)-110.8x
Ratio precio-beneficio (PE)¿Está CNVY sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de CNVY | |
---|---|
Ingresos | US$366.21m |
Coste de los ingresos | US$218.98m |
Beneficio bruto | US$147.23m |
Otros gastos | US$154.18m |
Beneficios | -US$6.94m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | -0.095 |
Margen bruto | 40.20% |
Margen de beneficio neto | -1.90% |
Ratio deuda/patrimonio | 50.0% |
¿Cómo se ha desempeñado CNVY a largo plazo?
Ver rendimiento histórico y comparativa